JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujimura, S.
Right arrow Articles by Nakada, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujimura, S.
Right arrow Articles by Nakada, T.

The Journal of Thoracic and Cardiovascular Surgery, Vol 90, 161-166, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Prognostic evaluation of tracheobronchial reconstruction for bronchogenic carcinoma

S Fujimura, T Kondo, T Imai, A Yamauchi, M Handa, T Okabe and T Nakada

Fifty-two patients have undergone tracheobronchial reconstruction for bronchogenic carcinomas over a 20 year period and have been evaluated from the view point of prognosis. Five-year survival rates of the patients undergoing reconstructive operations were as follows: 35% for the total group, 50% for those with squamous cell carcinoma, and 64% for those with Stage I and II disease. No patients with adenocarcinoma or Stage III disease have survived more than 5 years. However, the number of patients with early adenocarcinoma was too small for us to conclude that the histologic type per se affected survival. Six of eight patients with sleeve lobectomy and pulmonary artery reconstruction died within 2 years, 7 months postoperatively. Five of seven patients died within 1 year after carinal reconstruction. However, two are alive at 4 months and 2 years, 9 months after left or right sleeve pneumonectomy. In summary, any types of lobectomy or pneumonectomy with reconstruction of the tracheobronchial tree can be conducted in patients with Stage I and II lung cancer. Sleeve lobectomy with pulmonary artery reconstruction can be an alternative to pneumonectomy when pneumonectomy is contraindicated because of low cardiopulmonary reserve. In patients undergoing reconstruction of the carina, prophylactic radiation therapy may be necessary during the postoperative course.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Mitchell, D. J. Mathisen, C. D. Wright, J. C. Wain, D. M. Donahue, J. S. Allan, A. C. Moncure, and H. C. Grillo
Resection for bronchogenic carcinoma involving the carina: Long-term results and effect of nodal status on outcome
J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. B. Shrager, E. S. Lambright, C. M. McGrath, P. M. Wahl, M. E. Deeb, J. S. Friedberg, and L. R. Kaiser
Lobectomy with tangential pulmonary artery resection without regard to pulmonary function
Ann. Thorac. Surg., July 1, 2000; 70(1): 234 - 239.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1985 by The American Association for Thoracic Surgery.